Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Emily M. Leproust

Tracked across 2 events · 12 articles · First seen Jun 12, 2026 · Last active Sep 16, 2026

Sentiment
30
Attention
3
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
3 50
Tech
Impact: As CEO and co-founder of Altor BioScience, Emily M. Leproust highlighted the flexibility and ease of adoption that advanced automation brings to their hybrid capture portfolio.
Jun 12, 2026 · 6 articles
2 10
Business
Altor BioScience Corporation announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company. Under the agreement, Twist will provide antibody characterization data services for TuneLab, including for…
Impact: As Altor BioScience CEO and co-founder, Emily M. Leproust publicly endorsed the agreement, highlighting Twist's scale and high-throughput capabilities for generating reliable antibody characterization data.
Sep 16, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Emily M. Leproust live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.